SCHEMBL7984698

SCHEMBL7984698

NC(=O)c1c(NC(=O)c2ccccc2F)ncn1CCCOc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 1/20 0.38
P4HTM Q9NXG6 1/20 0.38
RAB9A P51151 1/20 0.38
ICMT O60725 1/20 0.37
MET P08581 1/20 0.37
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992375 0.95 SMN1; SMN2 (0.44) SMN1; SMN2LMNAKDM4EKMT2AMEN1
SCHEMBL7987763 0.87 RAB9A (0.44) SMN1; SMN2KMT2AMEN1SIRT2SIRT1
SCHEMBL7974240 0.85 RAB9A (0.47) SMN1; SMN2KDM4EKMT2AMEN1SIRT2
SCHEMBL7991521 0.82 ADORA3 (0.47) SMN1; SMN2KDM4EKMT2AMEN1SIRT2
SCHEMBL7987837 0.81 RECQL (0.47) SMN1; SMN2LMNAKDM4EKMT2AMEN1
SCHEMBL7987920 0.80 TP53 (0.47) SMN1; SMN2LMNAKDM4EKMT2AMEN1
SCHEMBL7987851 0.78 LMNA (0.46) SMN1; SMN2LMNAKMT2AMEN1TDP1
SCHEMBL7988637 0.78 NPC1 (0.51) SMN1; SMN2KDM4EKMT2AMEN1SIRT2
SCHEMBL7991269 0.76 TP53 (0.46) SMN1; SMN2LMNAKDM4EKMT2AMEN1
SCHEMBL7987988 0.75 GAA (0.47) SMN1; SMN2LMNAKMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed